Literature DB >> 12587102

Group sequential design for comparative diagnostic accuracy studies.

Madhu Mazumdar1, Aiyi Liu.   

Abstract

In the field of diagnostic medicine, comparative clinical trials are necessary for assessing the utility of one diagnostic test over another. The area under the receiver operating characteristic (ROC) curve, commonly referred to as AUC, is a general measure of a test's inherent ability to distinguish between patients with and without a condition. Standardized AUC difference is the most frequently used statistic for comparing two diagnostic tests. In therapeutic comparative clinical trials with sequential patient entry, fixed sample design (FSD) is unjustified on ethical and economical grounds and group sequential design (GSD) is frequently used. In this paper, we argue that the same reasoning exists for the comparative clinical trials in diagnostic medicine and hence GSD should be utilized in this field for designing trials. Since computation of the stopping boundaries of GSD and data analysis after a group sequential test rely heavily on Brownian motion approximation, we derive the asymptotic distribution of the standardized AUC difference statistic and point out its resemblance to the Brownian motion. Boundary determination and sample size calculation are then illustrated through an example from a cancer clinical trial. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12587102     DOI: 10.1002/sim.1386

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  12 in total

1.  Nonparametric sequential evaluation of diagnostic biomarkers.

Authors:  Aiyi Liu; Chengqing Wu; Enrique F Schisterman
Journal:  Stat Med       Date:  2008-05-10       Impact factor: 2.373

2.  Conditional estimation of sensitivity and specificity from a phase 2 biomarker study allowing early termination for futility.

Authors:  Margaret Sullivan Pepe; Ziding Feng; Gary Longton; Joseph Koopmeiners
Journal:  Stat Med       Date:  2009-02-28       Impact factor: 2.373

3.  Sample size recalculation in sequential diagnostic trials.

Authors:  Liansheng Larry Tang; Aiyi Liu
Journal:  Biostatistics       Date:  2009-10-12       Impact factor: 5.899

4.  Interim analyses in diagnostic versus treatment studies: differences and similarities.

Authors:  Oke Gerke; Poul Flemming Høilund-Carlsen; Mads Hvid Poulsen; Werner Vach
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

5.  Early termination of a two-stage study to develop and validate a panel of biomarkers.

Authors:  Joseph S Koopmeiners; Rachel Isaksson Vogel
Journal:  Stat Med       Date:  2012-10-02       Impact factor: 2.373

6.  Conditional estimation after a two-stage diagnostic biomarker study that allows early termination for futility.

Authors:  Joseph S Koopmeiners; Ziding Feng; Margaret Sullivan Pepe
Journal:  Stat Med       Date:  2012-01-12       Impact factor: 2.373

7.  Repeated significance tests of linear combinations of sensitivity and specificity of a diagnostic biomarker.

Authors:  Mixia Wu; Yu Shu; Zhaohai Li; Aiyi Liu
Journal:  Stat Med       Date:  2016-03-07       Impact factor: 2.373

8.  Optimal sampling ratios in comparative diagnostic trials.

Authors:  Ting Dong; Liansheng Larry Tang; William F Rosenberger
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2014-04       Impact factor: 1.864

9.  Group sequential testing of the predictive accuracy of a continuous biomarker with unknown prevalence.

Authors:  Joseph S Koopmeiners; Ziding Feng
Journal:  Stat Med       Date:  2015-11-04       Impact factor: 2.373

10.  Studies for the Evaluation of Diagnostic Tests–Part 28 of a Series on Evaluation of Scientific Publications.

Authors:  Annika Hoyer; Antonia Zapf
Journal:  Dtsch Arztebl Int       Date:  2021-08-23       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.